Smart Agents, Smarter Science

This IDC Perspective focuses on the agentic AI landscape, evolving regulations, challenges and solutions, and key takeaways for the life sciences technology buyer."From protocol authoring to PV triaging, from static pipelines to self-driving discovery engines, and from bench to bedside, AI agents are moving the needle for the life sciences industry. Regulatory-grade validation and continuous observability will be critical to ensure that every action is safe, explainable, and auditable. Yes, the agents are coming, and the disruption will be real," said Dr. Nimita Limaye, research VP, Life Sciences R&D Strategy and Technology, IDC.